IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
1-Year Est. Return
40.53%
1 Year Est. Return
+40.53%
AUM
$1.07B
AUM Growth
+$168M
(+19%)
Holding
98
Top Buys
| 1 | +$26.9M | |
| 2 | +$26.3M | |
| 3 | +$23.5M | |
| 4 |
Eli Lilly
LLY
|
+$19.5M |
| 5 |
Charles River Laboratories
CRL
|
+$17.4M |
Top Sells
| 1 | +$19.6M | |
| 2 | +$15.6M | |
| 3 | +$12.8M | |
| 4 |
Krystal Biotech
KRYS
|
+$10.8M |
| 5 |
Boston Scientific
BSX
|
+$10.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$33.7B
| $161M | 14.74% |
1,600,000
+50,000
|
|
||
|
2
Boston Scientific
BSX
$150B
| $59.1M | 5.41% |
550,000
-100,000
|
|
||
3
Tenet Healthcare
THC
$18.6B
| $48.4M | 4.43% |
275,000
|
|
||
4
Encompass Health
EHC
$12.7B
| $39.2M | 3.59% |
320,000
+50,000
|
|
||
5
Mineralys Therapeutics
MLYS
$3.1B
| $36.5M | 3.34% |
2,700,000
+400,000
|
|
||
6
Cytokinetics
CYTK
$6.92B
| $33M | 3.02% |
1,000,000
-100,000
|
|
||
7
BrightSpring Health Services
BTSG
$6.03B
| $29.5M | 2.7% |
1,250,000
+475,000
|
|
||
8
Vera Therapeutics
VERA
$1.86B
| $27.1M | 2.48% |
1,150,000
|
|
||
9
Quest Diagnostics
DGX
$20.3B
| $26.9M | 2.47% |
+150,000
|
|
||
10
Regeneron Pharmaceuticals
REGN
$61.3B
| $26.3M | 2.4% |
+50,000
|
|
||
11
Novartis
NVS
$252B
| $24.2M | 2.22% |
200,000
-50,000
|
|
||
12
Cardinal Health
CAH
$38.5B
| $23.5M | 2.15% |
+140,000
|
|
||
13
Elevance Health
ELV
$76.1B
| $23.3M | 2.14% |
60,000
-5,000
|
|
||
14
RadNet
RDNT
$6.43B
| $22.8M | 2.08% |
400,000
+150,000
|
|
||
15
Fresenius Medical Care
FMS
$16B
| $21.4M | 1.96% |
750,000
+70,000
|
|
||
|
16
Eli Lilly
LLY
$740B
| $19.5M | 1.78% |
+25,000
|
|
||
17
Neurocrine Biosciences
NBIX
$14.3B
| $18.9M | 1.73% |
150,000
|
|
||
18
uniQure
QURE
$3.76B
| $18.8M | 1.72% |
1,350,000
+100,000
|
|
||
19
Alnylam Pharmaceuticals
ALNY
$60.7B
| $17.9M | 1.64% |
55,000
+5,000
|
|
||
20
DexCom
DXCM
$27.6B
| $17.5M | 1.6% |
200,000
+100,000
|
|
||
|
21
Charles River Laboratories
CRL
$9.7B
| $17.4M | 1.6% |
+115,000
|
|
||
22
Medtronic
MDT
$120B
| $17.4M | 1.6% |
200,000
-100,000
|
|
||
23
CVS Health
CVS
$104B
| $17.2M | 1.58% |
250,000
+50,000
|
|
||
24
Pfizer
PFE
$141B
| $17M | 1.55% |
700,000
+400,000
|
|
||
25
Edwards Lifesciences
EW
$44.7B
| $15.6M | 1.43% |
200,000
+75,000
|
|